Lord Bishop of Oxford
Main Page: Lord Bishop of Oxford (Bishops - Bishops)(13 years, 11 months ago)
Lords Chamber
To ask Her Majesty’s Government what plans they have to review scientific developments in stem cell research, as recommended by the Select Committee on Stem Cell Research (Session 2001–02, HL Paper 83), with a view to ascertaining whether research on human embryos is still necessary.
My Lords, current scientific evidence supports research involving all forms of adult and embryonic stem cells rather than focusing on any distinct type. Investments in stem cell research are always evaluated against the current understanding of the science and of its application. The noble and right reverend Lord, Lord Harries, will be pleased to note, having chaired the Select Committee on Stem Cell Research, that the Government are in the process of taking stock of developments in regenerative medicine, and that this review will inform strategies to support the development of regenerative medicine in the United Kingdom.
I thank the Minister for her reply. Does she not agree not only that the issue is of general scientific importance, but that it is important to ensure that the Human Fertilisation and Embryology Act is properly observed? The HFEA is allowed to award a licence to a research project only if there is no way of doing the research other than by using embryos. In the debates in this House, it was not only the Government who accepted the recommendation that there should be a review after 10 years; there was very broad support. Will the Government do their best to encourage a reputable medical body such as the Academy of Medical Sciences to undertake a scientific review of the whole field?
My Lords, this is a complicated subject. I will do my best and apologise if my answer is not exactly what the noble and right reverend Lord wants. Perhaps he will write to me again if it is not. The UK has a strictly regulated but facilitating system that allows all forms of stem cell research to take place under licence. It is not yet clear that research on adult stem cells will be the best approach in all cases. Enabling scientists to work on all forms of stem cells can help accelerate the process of finding alternatives to embryonic stem cells where appropriate. The Government continue to support this because at this stage we do not know from where the major advances in knowledge and the development of cures will come, and it is too early to tell whether iPS cells will be a viable alternative to embryonic stem cells.